Contributing writer · PharmD, PhD (Pharmacology)
A Pharm-D and PhD in Pharmacology from Punjab University College of Pharmacy, and I have worked as a registered hospital pharmacist at Jinnah Hospital Lahore. Over the past six years in clinical practice, I have seen…
A Pharm-D and PhD in Pharmacology from Punjab University College of Pharmacy, and I have worked as a registered hospital pharmacist at Jinnah Hospital Lahore. Over the past six years in clinical practice, I have seen how confusing medical information can be, even for professionals. That’s what pushed me toward writing. I have worked as a Member of Advisory Board for couple of Multinational Health firms. I specialize in turning dense research, clinical data, and regulatory details into content that’s clear, practical, and genuinely useful. Whether I am breaking down a study, reviewing a healthcare product, or writing patient friendly guidance, my goal is simple: accuracy first, clarity always. I believe good medical writing should inform, guide and build trust, not overwhelm the reader.
PharmD, PhD (Pharmacology)
Neurology
Pooled evidence found no significant difference in functional independence or symptomatic intracerebral hemorrhage when CT perfusion and noncontrast CT were used to select patients for acute ischemic stroke treatment.
Dr. Abu Bakar · 6 min read
Health Policy
FDA materials recommend keeping three unapproved peptides off the 503A Bulks List, a step that could sharply restrict traditional pharmacies’ ability to compound them from bulk ingredients.
Dr. Abu Bakar · 6 min read
Cardiology
A 2026 meta-analysis found that digitalis glycosides reduced worsening heart failure events, but not cardiovascular death, reinforcing a selective rather than routine role.
Dr. Abu Bakar · 7 min read
Endocrinology & Metabolism
WHO is calling for stronger safety monitoring as GLP-1 use for weight loss grows worldwide. Clinicians need reliable prescribing, follow-up and adverse-event reporting systems.
Dr. Abu Bakar · 7 min read
Neurology
A multicenter phase 3 trial supports intravenous fosphenytoin for rapid relief during severe trigeminal neuralgia attacks. Its monitored administration and off-label US status limit where it can be used.
Dr. Abu Bakar · 6 min read
Clinical Briefs
FDA approval of RefluxStop requires a prospective study of 200 patients with GERD, reflecting unresolved questions about long-term implant safety, effectiveness and durability.
Dr. Abu Bakar · 6 min read
Cardiology
A 2026 meta-analysis estimated 32% lower odds of major cardiovascular events with semaglutide. The result supports cardiovascular benefit discussions but requires context on heterogeneity, absolute risk and indication.
Dr. Abu Bakar · 6 min read
Neurology
Small studies report improvements in fatigue, cognition, sleep and pain among people with long COVID, but a systematic review rates the evidence as low certainty.
Dr. Abu Bakar · 6 min read
Endocrinology & Metabolism
In a randomized trial, retatrutide monotherapy lowered glycated hemoglobin and body weight in adults with type 2 diabetes inadequately controlled by diet and exercise.
Dr. Abu Bakar · 6 min read
Infectious Disease
IDSA’s 2026 guidance reviews treatment of major drug-resistant pathogens and highlights decisions clinicians and stewardship programs should reassess as evidence evolves.
Dr. Abu Bakar · 7 min read
Infectious Disease
FDA is investigating 98 Salmonella Enteritidis illnesses, including 26 hospitalizations, linked to recalled shell eggs. A detailed food history can connect compatible illness to the July 24 recall.
Dr. Abu Bakar · 6 min read
Oncology
FDA approval of rusfertide creates a systemic option for adults with polycythemia vera whose erythrocytosis has traditionally required phlebotomy, with or without cytoreductive therapy.
Dr. Abu Bakar · 6 min read
Oncology
FDA approval makes vepdegestrant an option for adults with ESR1-mutated, ER-positive, HER2-negative advanced breast cancer after prior endocrine therapy.
Dr. Abu Bakar · 6 min read
Infectious Disease
CDC now recommends a five-day, 10-dose artemether-lumefantrine course for uncomplicated falciparum malaria and after IV artesunate, plus inpatient daily smears for falciparum, knowlesi or unknown species.
Dr. Abu Bakar · 6 min read
Endocrinology & Metabolism
REIMAGINE 3 found glycemic and weight benefits when cagrilintide-semaglutide was added to basal insulin in adults with type 2 diabetes. Hypoglycemia remains central to interpreting treatment escalation.
Dr. Abu Bakar · 6 min read
Innovation & Devices
FDA advisers examined whether deramiocel’s cardiac and upper-limb findings outweigh uncertainties in the evidence and risks of repeated cell infusions for Duchenne muscular dystrophy.
Dr. Abu Bakar · 7 min read
Oncology
The FDA granted accelerated approval to vusolimogene oderparepvec plus nivolumab for unresectable advanced melanoma progressing after PD-1 therapy, based on tumor response and response durability.
Dr. Abu Bakar · 6 min read
Infectious Disease
Rapid case growth and very-high national risk in DRC warrant stronger clinical preparedness and cross-border surveillance, while WHO assesses global risk as low and advises against travel or trade restrictions.
Dr. Abu Bakar · 7 min read
Cardiology
The 2026 CKM guideline calls for earlier, integrated prevention when cardiovascular, kidney and metabolic risks coexist, with action spanning primary care, endocrinology, nephrology and cardiology.
Dr. Abu Bakar · 7 min read
Infectious Disease
A multistate outbreak linked to affected alfalfa sprouts requires exposure-specific histories, testing for both pathogens and prompt coordination with public health agencies.
Dr. Abu Bakar · 6 min read
Endocrinology & Metabolism
A secondary analysis found that finerenone reduced cardiovascular and kidney events across CKM stages in adults with type 2 diabetes and CKD, while favoring CKM stage regression over progression.
Dr. Abu Bakar · 7 min read
Endocrinology & Metabolism
Updated evidence supports SGLT inhibition across heart failure phenotypes, with the clearest benefit in preventing worsening heart failure. Mortality and safety findings require more nuanced interpretation.
Dr. Abu Bakar · 7 min read
Health Policy
A new WHO compendium standardizes clinical, operational and monitoring terminology for hypertension-control programs, giving health systems a shared basis for implementation, reporting and performance comparisons.
Dr. Abu Bakar · 6 min read
Infectious Disease
WHO has revised weight-band dosing and preferred antiretroviral regimens for newborns, infants and children. The changes affect neonatal prophylaxis, treatment initiation and dose review as children grow.
Dr. Abu Bakar · 6 min read
Oncology
The FDA has moved lutetium Lu-177 vipivotide tetraxetan into PSMA-positive metastatic hormone-sensitive prostate cancer when combined with an androgen receptor pathway inhibitor.
Dr. Abu Bakar · 7 min read
Oncology
A phase 3 trial found that daily ensartinib substantially prolonged disease-free survival after chemotherapy and complete resection of stage IB-IIIB ALK-positive NSCLC.
Dr. Abu Bakar · 6 min read
Neurology
Selected patients with salvageable brain tissue may benefit from IV thrombolysis 4.5 to 24 hours after ischemic stroke onset, although symptomatic intracranial hemorrhage risk is higher.
Dr. Abu Bakar · 6 min read
Cardiology
Aortic regurgitation is a common heart valve problem where the aortic valve doesn’t close tightly.
Dr. Abu Bakar · 6 min read
Cardiology
Cardio-oncology is an emerging field that brings cardiologists and oncologists together to prevent and treat heart and vascular problems
Dr. Abu Bakar · 7 min read
Clinical Briefs
Sirolimus conversion is an increasingly considered strategy for heart transplant recipients because it can change their long-term health risks….
Dr. Abu Bakar · 6 min read